3|0|Public
50|$|A known use of MMH {{is in the}} {{synthesis}} of <b>Suritozole.</b>|$|E
50|$|Well known {{pharmaceuticals}} prepared using MITC include Zantac and Tagamet. <b>Suritozole</b> {{is a third}} example.|$|E
50|$|<b>Suritozole</b> (MDL 26,479) is an investigational {{cognition}} enhancer. It acts as {{a partial}} inverse agonist at the benzodiazepine receptor site on the GABAA ion channel complex, but does not have either anxiogenic or convulsant effects, unlike other BZD inverse agonists such as DMCM. It was investigated {{for the treatment of}} depression and Alzheimer's disease, but clinical development seems to have been discontinued.|$|E

